Subgroup Analysis From the RE-DUAL PCI Trial : Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention — Jonas Oldgren (2017) | RDL Network
Subgroup Analysis From the RE-DUAL PCI Trial : Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Article 2017 en
Authors
JO
Jonas Oldgren
PS
Philippe Gabríel Steg
SH
Stefan H. Hohnloser
Abstract
1 min read
Subgroup Analysis From the RE-DUAL PCI Trial : Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Jonas Oldgren, Philippe Gabríel Steg, Stefan H. Hohnloser, Professor Gregory Lip, Stephen G. Ellis, Takeshi Kimura, Matias Nordaby, Jurriën M. ten Berg, Deepak L. Bhatt, Christopher P. Cannon, Eva Kleine
Michael Mæng, Philippe Gabríel Steg, Deepak L. Bhatt, Stefan H. Hohnloser, Matias Nordaby, Corinna Miede, Takeshi Kimura, Professor Gregory Lip, Jonas Oldgren, Jurriën M. ten Berg, Christopher P. Cannon
Christopher P. Cannon, Deepak L. Bhatt, Jonas Oldgren, Professor Gregory Lip, Stephen G. Ellis, Takeshi Kimura, Michael Mæng, Béla Merkely, Uwe Zeymer, Savion Gropper, Matias Nordaby, Eva Kleine, Ruth Harper, Jenny Manassie, James L. Januzzi, Jurriën M. ten Berg, Philippe Gabríel Steg, Stefan H. Hohnloser
Discussion(0)
No comments yet. Be the first to comment.